Published in Cancer Weekly, November 5th, 2002
The Vista CTR system combines the power of cutting-edge bipolar technology with ACMI's market leading cysto-resection systems. The product uses Coblation technology, licensed from ArthroCare Corporation (ARTC), and will be exclusively marketed by ACMI into urology. Coblation technology is a next-generation, bipolar electrosurgical technology that minimizes collateral tissue damage using a non-heat driven process. It has proven effective in over 1.75 million...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.